<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
CUBIST PHARMACEUTICALS, INC.
(Name of Issuer)
COMMON STOCK $.001 PAR VALUE
(Title of Class of Securities)
229 678 610
(CUSIP Number)
GINETTE DEPELTEAU
SOFINOV,
SOCIETE FINANCIERE D'INNOVATION, INC.
1981 MCGILL COLLEGE AVENUE
MONTREAL, QUEBEC HCA 3C7
(514) 847-5901
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
[FEBRUARY 11, 2000]
(Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rules 13d-1 (e), 13d-1(f) or 13d-1(g), check
the following box / /.
Note: Schedules filed in paper format shall include a signed original and
five copies of the schedule, including all exhibits. See Rule 13d-7 for other
parties to whom copies are to be sent.
(Continued on following pages)
- -----------------
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosure provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
1
<PAGE>
CUSIP No. 229 678 610
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
SOFINOV, SOCIETE FINANCIERE D'INNOVATION, INC.
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) / /1
(b) / /2
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS*: WC
- --------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) / /3
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
MONTREAL, QUEBEC, CANADA
- --------------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY 7. SOLE VOTING POWER:
OWNED BY EACH REPORTING PERSON 2,597,335(1)
WITH
----------------------------------------------
8. SHARED VOTING POWER:
--
----------------------------------------------
9. SOLE DISPOSITIVE POWER:
2,597,335
----------------------------------------------
10. SHARED DISPOSITIVE POWER:
--
- --------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,597,335
- --------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
/ /4
- --------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
9.72%
- --------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON: CO
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
(1) Includes 1,111,112 shares of Common Stock of the Company
issuable upon exercise of a warrant. See Item 4 below.
* SEE INSTRUCTIONS BEFORE FILLING OUT!
2
<PAGE>
CUSIP No. 229 678 610
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC.
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) / /5
(b) / /6
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS*: WC
- --------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) / /7
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
MONTREAL, QUEBEC, CANADA
- --------------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY 7. SOLE VOTING POWER:
OWNED BY EACH REPORTING PERSON 2,597,335(1)
WITH
----------------------------------------------
8. SHARED VOTING POWER:
--
----------------------------------------------
9. SOLE DISPOSITIVE POWER:
2,597,335
----------------------------------------------
10. SHARED DISPOSITIVE POWER:
--
- --------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,597,335
- --------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
/ / 8
- --------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
9.72%
- --------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON: CO
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
(1) Includes 1,111,112 shares of Common Stock of the Company
issuable upon exercise of a warrant. See Item 4 below.
* SEE INSTRUCTIONS BEFORE FILLING OUT!
3
<PAGE>
This Amendment No. 3, dated February 11, 2000 is being filed jointly
on behalf of Caisse de depot et placement du Quebec ("CDPQ") and by its
wholly-owned subsidiary, SOFINOV, Societe financiere d'innovation, inc.
("Sofinov") pursuant to Rule 13d-2(a) under the Securities Exchange Act of
1934, as amended (the "Exchange Act") pursuant to a Joint Filing Agreement
dated February 11, 2000, between CDPQ and Sofinov, a copy of which is
attached hereto as Exhibit 1.
ITEM 1. SECURITY AND ISSUER.
This Schedule 13D relates to the Common Stock, par value $.001 per
share ("Common Stock"), of Cubist Pharmaceuticals, Inc., a Delaware
corporation (the "Company"). The address of the principal executive
offices of the Company is 24 Emily Street, Cambridge, Massachusetts
02139.
ITEM 2. IDENTITY AND BACKGROUND
This Schedule 13D is filed jointly on behalf of CDPQ, a corporation
without share capital and an agent of the Crown in right of the
Province de Quebec, created by a special act of the Legislature of the
Province de Quebec, and Sofinov, a legal entity duly incorporated under
part 1A of the Companies ACT (Quebec) and a wholly-owned subsidiary of
CDPQ, pursuant to Rule 13d-1(f)(1) under the Exchange Act.
The principal business address and the principal office address of each
of CDPQ and Sofinov is 1981, Avenue McGill College, Suite 1330,
Montreal, Quebec, H3A 3C7, Canada. The name, business address,
citizenship and present principal occupation of each director and
executive officer of CDPQ and Sofinov are set forth on Schedule I.
To the best knowledge of CDPQ and Sofinov, none of the persons listed
on Schedule I has, during the last five years, (i) been convicted in a
criminal proceeding (excluding traffic violations or similar
misdemeanors) or (ii) been a party to a civil proceeding of a judicial
or administrative body of competent jurisdiction and as a result of
such proceeding was or is subject to a judgment, decree or final order
enjoining future violations of, or prohibiting or mandating activities
subject to, United States federal or state securities laws or finding
any violation with respect to such laws.
4
<PAGE>
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
All the funds required to purchase the Initial Shares (as defined
below) were obtained from the working capital of Sofinov.
ITEM 4. PURPOSE OF TRANSACTION
Pursuant to a Purchase Agreement (the "Purchase Agreement") dated
September 10, 1998, Sofinov acquired beneficial ownership of 3,497,335
shares of Common Stock in a private placement through (i) the purchase
of 2,386,223 shares of Common Stock (the "Initial Shares") and (ii) the
granting by the Company to Sofinov of a warrant (the "Warrant")
exercisable in whole or in part into 1,111,112 shares of Common Stock
(the "Warrant Shares") with an expiration date of September 23, 2003.
Pursuant to the exercise of certain registration rights granted to
Sofinov in connection with the private placement, the Initial Shares
and the Warrant Shares were registered for resale by Sofinov on a
Registration Statement on Form S-3 which was filed with the SEC on
September 30, 1998.
Sofinov sold 400,000 Initial Shares for US$16,586,817 as set forth on
Exhibit 2.
Pursuant to the Purchase Agreement, Sofinov has the right to designate
one person to be elected to the board of directors of the Company. The
Company has agreed to take all steps necessary and appropriate and
otherwise use its best efforts to cause the individual designated by
Sofinov to be duly and properly elected to the board of directors of
the Company. This right will terminate when Sofinov ceases to own at
least thirty-three and one-third percent (33 1/3%) of the Initial
Shares purchased by it under the Purchase Agreement.
Except as specifically set forth in this Item 4, neither CDPQ nor
Sofinov has any plans or proposals which relate to or would result in
any of the actions or effects set forth in items (a) through (e) of
Item 5 of Schedule 13D, although either of them may develop such plans
or proposals.
CDPQ and Sofinov intend to review on a continuing basis their
investment in the Company. As of the date of this Schedule 13D, no
determination has been made by CDPQ or Sofinov to acquire additional
shares of Common Stock or dispose of any shares of Common Stock now
held by them, although either of them may decide
5
<PAGE>
to so acquire or dispose of shares of Common Stock. Any such
determination will depend on market conditions prevailing from time
to time and on other conditions which may be applicable depending on
the nature of the transaction or transactions involved.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) With recent transactions, Sofinov is the direct beneficial owner of
2,597,335 shares of Common Stock (including the Warrant Shares)(the
"Sofinov Shares"). CDPQ may be deemed to be the indirect, beneficial
owner of the Sofinov Shares. The Sofinov Shares represent approximately
9.72% of the 25,605,455 shares of Common Stock of the Company
outstanding on the date hereof, based upon information provided by the
company, plus the Warrant Shares.
(b) CDPQ has the power to vote and dispose of the Sofinov Shares.
(c) Except as set forth in this Schedule 13D, none of CDPQ, Sofinov or, to
the best knowledge of CDPQ or Sofinov, any person named on Schedule I
hereto, owns any shares of the Company's Common Stock, and none has
purchased or sold any shares of the Company's Common Stock during the
past 60 days.
(d) Except as set forth in this Schedule 13D, no person is known by CDPQ or
Sofinov to have the right to receive or the power to direct the receipt
of dividends from, or the proceeds from the sale of, the shares of
Common Stock of the Company beneficially owned by CDPQ and Sofinov.
(e) Not applicable.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER
Except as set forth in this Schedule 13D, there are no contracts,
arrangements, understandings or relationships (legal or otherwise)
among the persons referred to in Item 2 of this Schedule 13D or between
such persons and any other person with respect to any of the securities
of the Company, including, but not limited to, any relating to the
transfer or voting of any of such securities, finder's fees, joint
ventures, loan or option arrangements, puts or calls, guarantees of
profits, division of profits or loss or the giving or withholding of
proxies.
6
<PAGE>
ITEM 7. MATERIALS TO BE FILED AS EXHIBITS
1. Joint Filing Agreement dated February 11, 2000 by and
between Sofinov and CDPQ.
2. Joint Filing Table of Dates, Number of Shares sold and price
per Share of Sales.
SIGNATURES
After reasonable inquiry and to the best knowledge and belief of the
undersigned, the undersigned certifies that the information set forth in this
statement is true, complete and correct.
Date: February 11, 2000
SOFINOV, SOCIETE FINANCIERE D'INNOVATION, INC.
By:
-------------------------------------------
Name: Ginette Depelteau
Title: Corporate Secretary
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC.
By:
-------------------------------------------
Name: Ginette Depelteau
Title: General Secretary - Director
7
<PAGE>
SCHEDULE I
LIST OF EXECUTIVE OFFICERS AND DIRECTORS OF SOFINOV
<TABLE>
<CAPTION>
DIRECTORS BUSINESS ADDRESS PRINCIPAL OCCUPATION
<S> <C> <C>
Jean-Claude Scraire Caisse de depot et placement du Quebec Chairman
1981, Avenue McGill College
Montreal (Quebec) H3A 3C7
Line Boisvert Caisse de depot et placement du Quebec Director and
1981, Avenue McGill College Portfolio Manager
Montreal (Quebec) H3A 3C7
Jacques M. Brault Levesque Beaubien Geoffrion Inc. Senior
1155, Metcalfe, 5e etage Vice-President
Montreal, (Qubec) H3B 4S9
Denis Dionne SOFINOV, Societe financiere d'innovation, inc. President
1981, Avenue McGill College
Montreal (Quebec) H3A 3C7
Claude Lajeunesse Ryerson Polytechnic University President and Vice
350, Victoria Street Chancellor
Toronto (Ontario) H2M 2V1
Serge Martin Martin International President
500, Place d'Armes, Suite 2910
Montreal, (Qubec) H2Y 2W2
Guy Morneau Regie des rentes du Quebec Chairman of the
2600 boul. Laurieir, bureau 546 Board and President
Qubec (Qubec) G1V 4T3
Normand Provost Caisse de depot et placement du Quebec Vice-President
1981, Avenue McGill College Coordinator
Montreal (Quebec) H3A 3C7
</TABLE>
8
<PAGE>
SCHEDULE 1
LIST OF EXECUTIVE OFFICERS AND DIRECTORS OF SOFINOV
<TABLE>
<CAPTION>
OFFICERS BUSINESS ADDRESS PRINCIPAL OCCUPATION
<S> <C> <C>
Jean-Claude Scraire Caisse de depot et placement du Quebec Chairman
1981, Avenue McGill College
Montreal (Quebec) H3A 3C7
Denis Dionne SOFINOV, Societe financiere d'innovation, inc. President
1981, Avenue McGill College
Montreal (Quebec) H3A 3C7
Pierre Pharand SOFINOV, Societe financiere d'innovation, inc. Vice-President
1981, Avenue McGill College
Montreal (Quebec) H3A 3C7
Bertrand Lauzon Caisse de depot et placement du Quebec Vice-President,
1981, Avenue McGill College Finance and Control
Montreal (Quebec) H3A 3C7
Ginette Depelteau Caisse de depot et placement du Quebec Secretary
1981, Avenue McGill College
Montreal (Quebec) H3A 3C7
</TABLE>
9
<PAGE>
SCHEDULE 1
LIST OF EXECUTIVE OFFICERS AND DIRECTORS OF CDPQ
<TABLE>
<CAPTION>
DIRECTORS BUSINESS ADDRESS PRINCIPAL OCCUPATION
<S> <C> <C>
Jean-Claude Scraire Caisse de depot et placement du Quebec Chairman
1981, avenue McGill College
Montreal (Quebec) H3A 3C7
Guy Morneau Regie des rentes du Quebec Chairman of the Board
2600, boul. Laurier, bureau 546 and President
Quebec (Quebec) G1V 4T3
Jean-Claude Bachand Byers Casgrain Lawyer
1, Place Ville-Marie
Bureau 3900
Montreal (Quebec) H3B 4M7
Claude Beland La Confederation des Caisses populaires et President
d'economie Desjardins du Quebec
100, avenue des Commandeurs
Levis (Quebec) G6V 7N5
Luc Bessette Commission administrative des regimes President
de retraite et d'assurances
475, rue Saint-Amable
Quebec (Quebec) G1R 5X3
Rodrigue Biron Rodrigue Biron & Associes
305, chemin de la Place St-Laurent
St-Augustin-de-Desmaures
Cap-Rouge (Quebec) G1Y 3G9
Yves Filion Hydro-Quebec Deputy Chief
75, boul. Rene-Levesque Ouest Executive Officer
Montreal (Quebec) and Chief Financial
H2Z 1A4 Officer
Jean-Yves Gagnon Societe de l'assurance automobile du Quebec General Manager
333, boul. Jean-Lesage
Quebec (Quebec) G1K 8J6
Henri Masse Federation des travailleurs et travailleuses du President
Quebec
545, boul. Cremazie Est, 17e etage
Montreal, (Quebec) H2M 2V1
</TABLE>
10
<PAGE>
SCHEDULE 1
LIST OF EXECUTIVE OFFICERS AND DIRECTORS OF CDPQ
<TABLE>
<CAPTION>
DIRECTORS BUSINESS ADDRESS PRINCIPAL OCCUPATION
<S> <C> <C>
Gilles Godbout Ministere des Finances Deputy Minister
12, rue St-Louis
Quebec (Quebec) G1R 5L3
Thomas O. Hecht Technologies IBEX Inc. Chairman Emeritus
5485, rue Pare
Montreal (Quebec) H4P 1P7
Marc Laviolette Confederation des syndicats nationaux President
1601, rue Delorimier
Montreal (Quebec) H2K 4M5
Nicole Trudeau Commission municipale du Quebec Vice-President
2, Complexe Desjardins
Suite 3100, East Tower
Montreal (Quebec) H5B 1B2
</TABLE>
11
<PAGE>
SCHEDULE 1
LIST OF EXECUTIVE OFFICERS AND DIRECTORS OF CDPQ
<TABLE>
<CAPTION>
OFFICERS BUSINESS ADDRESS PRINCIPAL OCCUPATION
<S> <C> <C>
Jean-Claude Scraire Caisse de depot et placement du Quebec Chairman
1981, avenue McGill College
Montreal (Quebec) H3A 3C7
Fernand Perreault Same Senior Vice-president
Caisse Real Estate Group
and Mortgage Investments
Michel Nadeau Same Senior Vice-president
Investment Planning and
Strategic Affairs
Ginette Depelteau Same General Secretary -
Director
</TABLE>
12
<PAGE>
EXHIBIT INDEX
EXHIBIT
1. Joint Filing Agreement dated February 11, 2000 by and between Sofinov and
CDPQ.
2. Joint Filing Table of Dates, Number of Shares sold and price per Share of
Sales.
13
<PAGE>
EXHIBIT 1
AGREEMENT
The undersigned hereby agree that this statement on Schedule 13D
with respect to beneficial ownership of shares of common stock of Cubist
Pharmaceuticals, Inc. is filed jointly, on behalf of each of them.
Dated: February 11, 2000
SOFINOV, SOCIETE FINANCIERE D'INNOVATION, INC.
By:
---------------------------------------------
Name: Denis Dionne
Title: President
By:
---------------------------------------------
Name: Ginette Depelteau
Title: Corporate Secretary
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC.
By:
---------------------------------------------
Name: Michel Nadeau
Title: Senior Vice-president
Investment Planning and Strategic
Affairs
By:
---------------------------------------------
Name: Ginette Depelteau
Title: General Secretary - Director
14
<PAGE>
EXHIBIT 2
- --------------------------------------------------------------------------------
TABLE OF SALES OF
CUBIST PHARMACEUTICALS, INC.
- --------------------------------------------------------------------------------
SALES
- --------------------------------------------------------------------------------
<TABLE>
<CAPTION>
PRICE PER SHARE
DATE NUMBER OF SHARES IN CDN DOLLARS
- ---- ---------------- --------------
<S> <C> <C>
February
01 25,000 35.31 *
02 115,000 36.78 *
03 30,000 38.12 *
04 25,000 40.12 *
07 75,000 46.65 *
08 40,000 46.28 *
10 75,000 43.67 *
11 15,000 46.87 *
</TABLE>
* Sales effected in United States
15
